Anesthesia in the patient for awake craniotomy.

Area of Science:

• Neurosurgery
• Anesthesiology
• Neurophysiology

Background:

• Neurosurgical procedures are increasingly less invasive, reducing the need for deep general anesthesia.
• Awake craniotomies are becoming more common for procedures requiring brain mapping and neurophysiologic testing.
• Maintaining patient comfort and cooperation is crucial during awake neurosurgery.

Purpose of the Study:

• To review current anesthetic management strategies for awake craniotomies.
• To identify anesthetic agents that provide adequate sedation and analgesia without interfering with neurophysiologic monitoring.
• To evaluate the safety and efficacy of specific anesthetic regimens.

Main Methods:

• Literature review of current anesthetic practices for awake craniotomies.
• Analysis of anesthetic agents and techniques used to ensure patient comfort and electrophysiologic monitoring.
• Evaluation of outcomes associated with different anesthetic approaches.

Main Results:

• The shift towards less invasive neurosurgery has decreased the demand for prolonged, deep general anesthesia.
• Adequate analgesia and sedation are essential for awake craniotomies, particularly for brain mapping and neurophysiologic testing.
• Dexmedetomidine, alone or combined with remifentanil, provides a safe and effective analgesic/amnestic state.

Conclusions:

• Dexmedetomidine is a key agent in the anesthetic management of awake craniotomies.
• The combination of dexmedetomidine and remifentanil offers a viable option for achieving optimal patient state during these procedures.
• Current anesthetic strategies focus on balancing sedation, analgesia, and unimpeded neurophysiologic monitoring.